PALIPERIDONE
Generic: PALIPERIDONE
Tris Pharma IncManufacturer
ORALRoute
PALIPERIDONEActive Substance
2020-10-29Original Approval
PALIPERIDONE is FDA application ANDA212807, sponsored by CSPC OUYI. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
929 reports
2
SEDATION
475 reports
3
DYSKINESIA
442 reports
4
DYSTONIA
439 reports
5
SUICIDE ATTEMPT
421 reports
6
SCHIZOPHRENIA
417 reports
7
SEXUAL DYSFUNCTION
332 reports
8
BLOOD GLUCOSE INCREASED
329 reports
9
CONDITION AGGRAVATED
310 reports
10
DRUG INTERACTION
310 reports